Cleared Traditional

K250105 - Boomerang Valvulotome (BMGVT080) (FDA 510(k) Clearance)

Also includes:
Boomerang Push Valvulotome (BMGPVT125)
Jul 2025
Decision
169d
Days
Class 2
Risk

K250105 is an FDA 510(k) clearance for the Boomerang Valvulotome (BMGVT080). This device is classified as a Valvulotome (Class II - Special Controls, product code MGZ).

Submitted by Aveera Medical, Inc. (San Clemente, US). The FDA issued a Cleared decision on July 3, 2025, 169 days after receiving the submission on January 15, 2025.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4885.

Submission Details

510(k) Number K250105 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 15, 2025
Decision Date July 03, 2025
Days to Decision 169 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MGZ - Valvulotome
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.4885